Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Telephone And Data Systems Pref | TDS-U | Sep 27, 2024 | 21.92 | +0.09 |
Telephone And Data Systems VV Pref | TDS-V | Sep 27, 2024 | 20.13 | +0.15 |
Telesat | TSAT | Sep 27, 2024 | 13.40 | +10.47 |
Telesis Bio | TBIO | Sep 27, 2024 | 3.23 | -19.05 |
Tellurian | TELL | Sep 27, 2024 | 0.97 | 0.00 |
Telomir Pharmaceuticals | TELO | Sep 27, 2024 | 6.82 | +5.57 |
Telos | TLS | Sep 27, 2024 | 3.48 | +1.16 |
Telus | TU | Sep 27, 2024 | 16.77 | +0.66 |
Telus International | TIXT | Sep 27, 2024 | 3.79 | +4.99 |
Tempest Therapeutics | TPST | Sep 27, 2024 | 1.37 | +5.38 |
Templeton Dragon Fund | TDF | Sep 27, 2024 | 9.02 | +1.75 |
Templeton Emerging Markets | TEI | Sep 27, 2024 | 5.82 | +0.34 |
Templeton Emerging Markets Fund | EMF | Sep 27, 2024 | 13.77 | +1.32 |
Tempur Sealy International | TPX | Sep 27, 2024 | 54.78 | +1.35 |
Tempus AI | TEM | Sep 27, 2024 | 53.84 | +3.80 |
Tenable | TENB | Sep 27, 2024 | 39.92 | -0.40 |
Tenaris ADR | TS | Sep 27, 2024 | 31.57 | +2.37 |
Tenax Therapeutics | TENX | Sep 27, 2024 | 3.49 | +1.16 |
Tenaya Therapeutics | TNYA | Sep 27, 2024 | 1.99 | -1.73 |
Tencent Music Entertainment A ADR | TME | Sep 27, 2024 | 12.28 | +0.08 |
Tenet Healthcare | THC | Sep 27, 2024 | 163.22 | -1.04 |
Tennant | TNC | Sep 27, 2024 | 96.58 | 0.00 |
Tennessee Valley Authority C Pref | TVC | Sep 27, 2024 | 23.09 | +0.13 |
Tennessee Valley Authority E Pref | TVE | Sep 27, 2024 | 22.62 | -0.17 |
Tenon Medical | TNON | Sep 27, 2024 | 4.60 | -5.93 |
Teradata | TDC | Sep 27, 2024 | 30.35 | +0.63 |
Teradyne | TER | Sep 27, 2024 | 134.64 | -2.02 |
TeraWulf | WULF | Sep 27, 2024 | 4.94 | -2.56 |
Terex | TEX | Sep 27, 2024 | 52.74 | +1.29 |
Ternium ADR | TX | Sep 27, 2024 | 37.06 | +0.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.